Genetic variation at glucose and insulin trait loci and response to glucose–insulin–potassium (GIK) therapy: the IMMEDIATE trial
about
Genetic modifiers of response to glucose-insulin-potassium (GIK) infusion in acute coronary syndromes and associations with clinical outcomes in the IMMEDIATE trial.ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease.Glucose-Insulin-Potassium Alleviates Intestinal Mucosal Barrier Injuries Involving Decreased Expression of Uncoupling Protein 2 and NLR Family-Pyrin Domain-Containing 3 Inflammasome in Polymicrobial Sepsis.Common variants associated with changes in levels of circulating free fatty acids after administration of glucose-insulin-potassium (GIK) therapy in the IMMEDIATE trial.
P2860
Genetic variation at glucose and insulin trait loci and response to glucose–insulin–potassium (GIK) therapy: the IMMEDIATE trial
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Genetic variation at glucose a ...... ) therapy: the IMMEDIATE trial
@en
Genetic variation at glucose a ...... e to glucose–insulin–potassium
@nl
type
label
Genetic variation at glucose a ...... ) therapy: the IMMEDIATE trial
@en
Genetic variation at glucose a ...... e to glucose–insulin–potassium
@nl
prefLabel
Genetic variation at glucose a ...... ) therapy: the IMMEDIATE trial
@en
Genetic variation at glucose a ...... e to glucose–insulin–potassium
@nl
P2093
P2860
P356
P1476
Genetic variation at glucose a ...... ) therapy: the IMMEDIATE trial
@en
P2093
E Ainehsazan
G S Huggins
H P Selker
J R Beshansky
P2860
P2888
P356
10.1038/TPJ.2014.41
P577
2014-08-19T00:00:00Z
P6179
1028505859